MiR-۴۹۳ suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 117

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-18-10_013

تاریخ نمایه سازی: 3 آبان 1400

Abstract:

Objective(s):MiRNAs have been proposed to be key regulators of tumorigenesis, progression and metastasis. However, their effect and prognostic value in gastric cancer is still poorly known. Materials and Methods: Gastric cancer cell lines were cultured. Tissue samples obtained from ۳۶ gastric cancer patients were used for quantitative real-time PCR (qRT-PCR) analysis. The tissue microarrays (TMAs) consisted of ۱۲۶ cases of gastric carcinoma that were used for In situ hybridisation (ISH). Lentivirus plasmids were co-transfected into ۲۹۳FT cells. Cell migration was examined using wound-healing assays. Statistical analyses were performed using SPSS۱۶.۰ software. Results: In this study, we found that the expression levels of miR-۴۹۳ were strongly down-regulated in gastric cancer and were associated with clinical stage and the presence of lymph node metastases. Moreover, miR-۴۹۳ might independently predict OS and RFS in gastric cancer. We further found that up-regulation of miR-۴۹۳ inhibited the proliferation and metastasis of gastric cancer cells, in vitro and in vivo. In addition, miR-۴۹۳ directly targeted RhoC, which resulted in a marked reduction of the expression of mRNA and protein. This effect, in turn, led to a decreased ability of growth, invasion and metastasis in gastric cancer cells. Conclusion: Taken together, our findings demonstrate that miR-۴۹۳ is important for gastric cancer initiation and progression and holds promise as a prognostic biomarker to predict survival and relapse in gastric cancer. It is also a potential therapeutic tool to improve clinical outcomes in this disease.

Authors

Wenhua Zhou

Cancer Research Institute, University of South China, Key Laboratory of Cancer Cellular and Molecular Pathology of Hunan Provincial University, Hengyang, People&#۰۳۹;s Republic of China

Chi Zhang

Function Laboratory Center, Medical School, University of South China, Hengyang, Hunan, People’s Republic of China

Hao Jiang

Center for Gastric Cancer Research of Human Province, The First Affiliated Hospital, University of South China, Hengyang, Hunan, People&#۰۳۹;s Republic of China

Zhiwei Zhang

Cancer Research Institute, University of South China, Key Laboratory of Cancer Cellular and Molecular Pathology of Hunan Provincial University, Hengyang, People&#۰۳۹;s Republic of China

Liming Xie

Center for Gastric Cancer Research of Human Province, The First Affiliated Hospital, University of South China, Hengyang, Hunan, People&#۰۳۹;s Republic of China

Xiusheng He

Cancer Research Institute, University of South China, Key Laboratory of Cancer Cellular and Molecular Pathology of Hunan Provincial University, Hengyang, People&#۰۳۹;s Republic of China

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Hartgrink HH, Jansen EP, van Grieken NC, van de Velde ...
  • Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, ...
  • Tang H, Kong Y, Guo J, Tang Y, Xie X, ...
  • Tan Z, Jiang H, Wu Y, Xie L, Dai W, ...
  • German MA, Pillay M, Jeong DH, Hetawal A, Luo S, ...
  • Gu Y, Cheng Y, Song Y, Zhang Z, Deng M, ...
  • Cheng CJ, Slack FJ. The duality of oncomiR addiction in ...
  • Tang H, Deng M, Tang Y, Xie X, Guo J, ...
  • Zheng B, Liang L, Wang C, Huang S, Cao X, ...
  • Liu D, Xia P, Diao D, Cheng Y, Zhang H, ...
  • He XP, Shao Y, Li XL, Xu W, Chen GS, ...
  • Zhang L, Liu X, Jin H, Guo X, Xia L, ...
  • Qin S, Ai F, Ji WF, Rao W, Zhang HC, ...
  • Wang M, Li C, Yu B, Su L, Li J, ...
  • Wu W, Takanashi M, Borjigin N, Ohno SI, Fujita K, ...
  • Yang ZX, Lu CY, Yang YL, Dou KF, Tao KS. ...
  • Zhi Q, Guo X, Guo L, Zhang R, Jiang J, ...
  • Guo JX, Tao QS, Lou PR, Chen XC, Chen J, ...
  • Ueno K, Hirata H, Majid S, Yamamura S, Shahryari V, ...
  • Okamoto K, Ishiguro T, Midorikawa Y, Ohata H, Izumiya M, ...
  • Gao J, Li L, Wu M, Liu M, Xie X, ...
  • Zhang J, Zhang Y, Liu S, Zhang Q, Wang Y, ...
  • Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, ...
  • Hoshino D, Koshikawa N, Seiki M. A p۲۷(kip۱)-binding protein, p۲۷RF-Rho, ...
  • Karlsson R, Pedersen ED, Wang Z, Brakebusch C. Rho GTPase ...
  • Ikoma T, Takahashi T, Nagano S, Li YM, Ohno Y, ...
  • Shida A, Fujioka S, Takahashi N, Aoki H, Okamoto T, ...
  • Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, ...
  • نمایش کامل مراجع